Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ZEUS SCIENTIFIC

ZEUS Scientific provides high-performing, easy-to-use clinical diagnostic solutions. The company’s products are desig... read more Featured Products: More products

Download Mobile App





ZEUS Receives FDA EUA Approval for SARS-SoV-2 Tests on Dynex Instruments

By LabMedica International staff writers
Posted on 13 Sep 2021
ZEUS Scientific (Branchburg, NJ, USA) has received FDA authorization to run the ZEUS ELISA SARS-SoV-2 Total Antibody Test System using the Dynex Agility, Dynex DSX or Dynex DS2 Automated ELISA Systems from Dynex Technologies (Chantilly, VA, USA).

The ZEUS ELISA SARS-CoV-2 IgG Test System assay utilizes a dual antigen combination of recombinant S1 receptor binding domain (RBD) viral protein and recombinant nucleoprotein that detects immune responses that other antibody tests may miss.

The SARS-CoV-2 IgG Test system was first granted EUA in October of 2020 to run the ZEUS SARS-CoV-2 IgG Test System manually or using the Dynex Agility Automated ELISA System. More...
The FDA has extended the EUA to include the Dynex DS2 and Dynex DSX automated ELISA systems.

Related Links:
ZEUS Scientific
Dynex Technologies



Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.